Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) is a publicly traded Healthcare sector company. As of July 26, 2026, RYTM trades at $102.10 with a market cap of $7.00B and a P/E ratio of -32.86. RYTM moved -0.56% today. Year to date, RYTM is -4.62%; over the trailing twelve months it is +16.99%. Its 52-week range spans $45.91 to $122.20. Analyst consensus is strong buy with an average price target of $137.09. Rallies surfaces RYTM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for RYTM, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $102.10 |
| Market Cap | $7.00B |
| P/E Ratio | -32.86 |
| EPS | $-3.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $122.20 |
| 52-Week Low | $45.91 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $189.76M |
| Net Income | $-196.54M |
| Gross Margin | 89.73% |
12 analysts cover RYTM: 0 strong buy, 12 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $137.09.